ACAD

Acadia Pharmaceuticals Inc

25.32

Jun 26 • 04:00PM ET +1.60 (6.75%)

Healthcare Biotechnology USA Mid NASD

Peers: AXSM XENE NBIX BMRN VKTX INCY MDGL ALKS KROS BIIB

| Held by: IJR XBI VTI IWM VB VBK VXF IBB SPSM IJT

Scroll to Statements

Index	RUT	P/E	11.53	EPS (ttm)	2.20	Insider Own	1.31%	Shs Outstand	171.09M	Perf Week	17.11%
Market Cap	4.34B	Forward P/E	33.56	EPS next Y	0.75	Insider Trans	-2.15%	Shs Float	169.04M	Perf Month	19.49%
Enterprise Value	3.54B	PEG	-	EPS next Q	0.06	Inst Own	96.71%	Short Float	6.99%	Perf Quarter	17.93%
Income	375.65M	P/S	3.96	EPS this Y	-83.19%	Inst Trans	-0.61%	Short Ratio	7.34	Perf Half Y	-9.02%
Sales	1.10B	P/B	3.47	EPS next Y	95.10%	ROA	27.44%	Short Interest	11.81M	Perf YTD	-5.20%
Book/sh	7.29	P/C	5.09	EPS next 5Y	-14.58%	ROE	37.32%	52W High	28.35 -10.69%	Perf Year	14.00%
Cash/sh	4.97	P/FCF	38.17	EPS past 3/5Y	- -	ROIC	29.19%	52W Low	19.69 28.59%	Perf 3Y	6.12%
Dividend Est.	-	EV/EBITDA	38.13	Sales past 3/5Y	27.48% 19.39%	Gross Margin	91.47%	Volatility	4.88% 3.39%	Perf 5Y	-3.25%
Dividend TTM	-	EV/Sales	3.23	EPS Y/Y TTM	61.40%	Oper. Margin	7.39%	ATR (14)	0.92	Perf 10Y	-19.44%
Dividend Ex-Date	-	Quick Ratio	3.48	Sales Y/Y TTM	9.93%	Profit Margin	34.30%	RSI (14)	76.97	Recom	1.62
Dividend Gr. 3/5Y	- -	Current Ratio	3.59	EPS Q/Q	-81.36%	SMA20	15.47%	Beta	0.79	Target Price	32.10
Payout	0.00%	Debt/Eq	0.04	Sales Q/Q	9.72%	SMA50	15.88%	Rel Volume	4.58	Prev Close	23.72
Employees	798	LT Debt/Eq	0.03	Earnings	May 06 AMC	SMA200	8.93%	Avg Volume	1.61M	Price	25.32
IPO	May 27, 2004	Option/Short	Yes / Yes	EPS/Sales Surpr.	-60.40% -4.34%	Trades		Volume	7,365,293	Change	6.75%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)